{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T18:18:25Z","timestamp":1793902705859,"version":"4.8.0"},"reference-count":34,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,4]]},"abstract":"<jats:sec>\n            <jats:title>Background.<\/jats:title>\n            <jats:p>Recent studies identified underlying genetic causes in a proportion of patients with various forms of kidney disease. In particular, genetic testing reclassified some focal segmental glomerulosclerosis (FSGS) cases into collagen type 4 (COL4)-related nephropathy. This knowledge has major implications for counseling prospective transplant recipients about recurrence risk and screening biologically related donors. We describe our experience incorporating genetic testing in our kidney transplant multidisciplinary practice.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods.<\/jats:title>\n            <jats:p>Patients\u2019 DNA was analyzed using whole exome sequencing for a comprehensive kidney gene panel encompassing 344 genes associated with kidney diseases and candidate genes highly expressed in the kidney. Results were correlated with phenotype by a multidisciplinary committee of nephrologists, renal pathologists, geneticists, and genetic counselors. Between October 2018 and July 2020, 30 recipient and 5 donor candidates completed testing.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results.<\/jats:title>\n            <jats:p>Among recipient candidates, 24 (80%) carried the diagnosis of FSGS, 2 (6.7%) tubulointerstitial nephritis, and 1 (3.3%) nephrolithiasis, and 3 (10%) had an unknown cause of kidney disease. The yield for pathogenic\/likely pathogenic variants was 43.3%, with majority being COL4 variants (53.8%). Among those with FSGS diagnosis, the yield was 10 of 24 (41.6%), with 29% reclassified into a COL4-related nephropathy. Family history of kidney disease was the only clinical characteristic difference between recipients with positive and negative results (76.9 versus 29.4%; <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.025). One of 5 donors tested positive for a pathogenic\/likely pathogenic variant and was excluded from donation.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions.<\/jats:title>\n            <jats:p>We conclude that thoughtful use of genetic testing can be valuable for kidney donor selection and transplant recipient management.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/tp.0000000000004363","type":"journal-article","created":{"date-parts":[[2022,10,18]],"date-time":"2022-10-18T04:01:44Z","timestamp":1666065704000},"page":"952-960","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":22,"title":["Incorporation of Genetic Studies in the Kidney Transplant Evaluation Clinic: The Value of a Multidisciplinary Approach"],"prefix":"10.1097","volume":"107","author":[{"given":"Mireille","family":"El Ters","sequence":"first","affiliation":[{"name":"Division of Nephrology, Department of Internal Medicine, Mayo Clinic, Rochester, MN."},{"name":"William J. von Lie to the big Center for Transplantation and Clinical Regeneration, Mayo Clinic, Rochester, MN."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filippo","family":"Pinto e Vairo","sequence":"additional","affiliation":[{"name":"Department of Clinical Genomics, Mayo Clinic, Rochester, MN."},{"name":"Center for Individualized Medicine, Mayo Clinic, Rochester, MN."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carri","family":"Prochnow","sequence":"additional","affiliation":[{"name":"Center for Individualized Medicine, Mayo Clinic, Rochester, MN."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carrie","family":"Schinstock","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Internal Medicine, Mayo Clinic, Rochester, MN."},{"name":"William J. von Lie to the big Center for Transplantation and Clinical Regeneration, Mayo Clinic, Rochester, MN."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Dean","sequence":"additional","affiliation":[{"name":"William J. von Lie to the big Center for Transplantation and Clinical Regeneration, Mayo Clinic, Rochester, MN."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Kemppainen","sequence":"additional","affiliation":[{"name":"Center for Individualized Medicine, Mayo Clinic, Rochester, MN."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantinos","family":"Lazaridis","sequence":"additional","affiliation":[{"name":"Center for Individualized Medicine, Mayo Clinic, Rochester, MN."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Cosio","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Internal Medicine, Mayo Clinic, Rochester, MN."},{"name":"William J. von Lie to the big Center for Transplantation and Clinical Regeneration, Mayo Clinic, Rochester, MN."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando C.","family":"Fervenza","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Internal Medicine, Mayo Clinic, Rochester, MN."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynn","family":"Cornell","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hatem","family":"Amer","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Internal Medicine, Mayo Clinic, Rochester, MN."},{"name":"William J. von Lie to the big Center for Transplantation and Clinical Regeneration, Mayo Clinic, Rochester, MN."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie C.","family":"Hogan","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Internal Medicine, Mayo Clinic, Rochester, MN."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2023,3,31]]},"reference":[{"key":"R1-20250604","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1056\/NEJMoa1806891","article-title":"Diagnostic utility of exome sequencing for kidney disease.","volume":"380","author":"Groopman","year":"2019","journal-title":"N Engl J Med"},{"key":"R2-20250604","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.kint.2019.01.038","article-title":"Value of renal gene panel diagnostics in adults waiting for kidney transplantation due to undetermined end-stage renal disease.","volume":"96","author":"Ottlewski","year":"2019","journal-title":"Kidney Int"},{"key":"R3-20250604","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/s41585-020-0332-x","article-title":"Genetics of kidney stone disease.","volume":"17","author":"Howles","year":"2020","journal-title":"Nat Rev Urol"},{"key":"R4-20250604","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.kint.2020.04.038","article-title":"Clinical and genetic spectra of autosomal dominant tubulointerstitial kidney disease due to mutations in UMOD and MUC1.","volume":"98","author":"Olinger","year":"2020","journal-title":"Kidney Int"},{"key":"R5-20250604","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1038\/nrneph.2015.140","article-title":"Genetic, environmental, and epigenetic factors involved in CAKUT.","volume":"11","author":"Nicolaou","year":"2015","journal-title":"Nat Rev Nephrol"},{"key":"R6-20250604","doi-asserted-by":"crossref","first-page":"213","DOI":"10.2215\/CJN.08750718","article-title":"Integration of genetic testing and pathology for the diagnosis of adults with FSGS.","volume":"14","author":"Yao","year":"2019","journal-title":"Clin J Am Soc Nephrol"},{"key":"R7-20250604","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1097\/TP.0b013e31819f12be","article-title":"Kidney transplantation for primary focal segmental glomerulosclerosis: outcomes and response to therapy for recurrence.","volume":"87","author":"Hickson","year":"2009","journal-title":"Transplantation"},{"key":"R8-20250604","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.kint.2016.08.030","article-title":"Recent advances in our understanding of recurrent primary glomerulonephritis after kidney transplantation.","volume":"91","author":"Cosio","year":"2017","journal-title":"Kidney Int"},{"key":"R9-20250604","doi-asserted-by":"crossref","first-page":"2398","DOI":"10.1056\/NEJMra1106556","article-title":"Focal segmental glomerulosclerosis.","volume":"365","author":"D\u2019Agati","year":"2011","journal-title":"N Engl J Med"},{"key":"R10-20250604","doi-asserted-by":"crossref","DOI":"10.1159\/000510748","article-title":"Update on recurrent focal segmental glomerulosclerosis in kidney transplantation.","author":"Shoji","year":"2020","journal-title":"Nephron"},{"key":"R11-20250604","doi-asserted-by":"crossref","first-page":"3765608","DOI":"10.1155\/2016\/3765608","article-title":"Circulating permeability factors in primary focal segmental glomerulosclerosis: a review of proposed candidates.","volume":"2016","author":"K\u00f6nigshausen","year":"2016","journal-title":"Biomed Res Int"},{"key":"R12-20250604","doi-asserted-by":"crossref","first-page":"502","DOI":"10.2215\/CJN.05960616","article-title":"Focal segmental glomerulosclerosis.","volume":"12","author":"Rosenberg","year":"2017","journal-title":"Clin J Am Soc Nephrol"},{"key":"R13-20250604","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1681\/ASN.2017090958","article-title":"Differentiating primary, genetic, and secondary FSGS in adults: a clinicopathologic approach.","volume":"29","author":"De Vriese","year":"2018","journal-title":"J Am Soc Nephrol"},{"key":"R15-20250604","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1097\/TP.0000000000001770","article-title":"KDIGO clinical practice guideline on the evaluation and care of living kidney donors.","volume":"101","author":"Lentine","year":"2017","journal-title":"Transplantation"},{"key":"R16-20250604","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/S0272-6386(99)70435-X","article-title":"Focal segmental glomerulosclerosis: a need for caution in live-related renal transplantation.","volume":"33","author":"Winn","year":"1999","journal-title":"Am J Kidney Dis"},{"key":"R17-20250604","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1038\/ki.2011.452","article-title":"Incidence of renal failure and nephroprotection by RAAS inhibition in heterozygous carriers of X-chromosomal and autosomal recessive Alport mutations.","volume":"81","author":"Temme","year":"2012","journal-title":"Kidney Int"},{"key":"R18-20250604","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1093\/ndt\/gfn635","article-title":"Living donor kidney transplantation from relatives with mild urinary abnormalities in Alport syndrome: long-term risk, benefit and outcome.","volume":"24","author":"Gross","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"R19-20250604","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1111\/ajt.13970","article-title":"Screening of living kidney donors for genetic diseases using a comprehensive genetic testing strategy.","volume":"17","author":"Thomas","year":"2017","journal-title":"Am J Transplant"},{"key":"R20-20250604","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1038\/s41436-020-0772-y","article-title":"Initial experience from a renal genetics clinic demonstrates a distinct role in patient management.","volume":"22","author":"Thomas","year":"2020","journal-title":"Genet Med"},{"key":"R21-20250604","doi-asserted-by":"crossref","first-page":"490","DOI":"10.2215\/CJN.08461109","article-title":"A survey-based evaluation of self-perceived competency after nephrology fellowship training.","volume":"5","author":"Berns","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"R22-20250604","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.2215\/CJN.15141219","article-title":"Clinical genetic screening in adult patients with kidney disease.","volume":"15","author":"Cocchi","year":"2020","journal-title":"Clin J Am Soc Nephrol"},{"key":"R23-20250604","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.ekir.2020.12.008","article-title":"Assessing physician needs for the implementation of personalized care.","volume":"6","author":"Nestor","year":"2021","journal-title":"Kidney Int Rep"},{"key":"R24-20250604","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.ekir.2020.10.030","article-title":"Attitudes and practices of Australian nephrologists toward implementation of clinical genomics.","volume":"6","author":"Jayasinghe","year":"2021","journal-title":"Kidney Int Rep"},{"key":"R25-20250604","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/S0140-6736(94)92026-5","article-title":"Evaluation of ultrasonographic diagnostic criteria for autosomal dominant polycystic kidney disease 1.","volume":"343","author":"Ravine","year":"1994","journal-title":"Lancet"},{"key":"R26-20250604","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1681\/ASN.2008050507","article-title":"Unified criteria for ultrasonographic diagnosis of ADPKD.","volume":"20","author":"Pei","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"R27-20250604","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med"},{"key":"R28-20250604","doi-asserted-by":"crossref","first-page":"2749","DOI":"10.1681\/ASN.2016101084","article-title":"Quantifying postdonation risk of ESRD in living kidney donors.","volume":"28","author":"Massie","year":"2017","journal-title":"J Am Soc Nephrol"},{"key":"R29-20250604","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1111\/ajt.14678","article-title":"Risk of ESRD in prior living kidney donors.","volume":"18","author":"Wainright","year":"2018","journal-title":"Am J Transplant"},{"key":"R30-20250604","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1093\/ckj\/sfz176","article-title":"Prevalence of clinical, pathological and molecular features of glomerular basement membrane nephropathy caused by COL4A3 or COL4A4 mutations: a systematic review.","volume":"13","author":"Matthaiou","year":"2020","journal-title":"Clin Kidney J"},{"key":"R31-20250604","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1136\/jmg.39.12.882","article-title":"Mutations of the UMOD gene are responsible for medullary cystic kidney disease 2 and familial juvenile hyperuricaemic nephropathy.","volume":"39","author":"Hart","year":"2002","journal-title":"J Med Genet"},{"key":"R32-20250604","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/ng.2543","article-title":"Mutations causing medullary cystic kidney disease type 1 lie in a large VNTR in MUC1 missed by massively parallel sequencing.","volume":"45","author":"Kirby","year":"2013","journal-title":"Nat Genet"},{"key":"R33-20250604","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1016\/j.mayocp.2021.01.037","article-title":"Identification of genetic causes of focal segmental glomerulosclerosis increases with proper patient selection.","volume":"96","author":"Miao","year":"2021","journal-title":"Mayo Clin Proc"},{"key":"R34-20250604","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1038\/s41581-021-00427-1","article-title":"Therapeutic trials in adult FSGS: lessons learned and the road forward.","volume":"17","author":"De Vriese","year":"2021","journal-title":"Nat Rev Nephrol"},{"key":"R35-20250604","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1681\/ASN.2018060575","article-title":"Whole-exome sequencing enables a precision medicine approach for kidney transplant recipients.","volume":"30","author":"Mann","year":"2019","journal-title":"J Am Soc Nephrol"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0000000000004363","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T18:12:43Z","timestamp":1749060763000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0000000000004363"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,31]]},"references-count":34,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/tp.0000000000004363","relation":{},"ISSN":["0041-1337"],"issn-type":[{"value":"0041-1337","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3,31]]}}}